Haloperidol, thioridazine and placebo in mentally subnormal patients – serum levels and clinical effects

Acta Psychiatrica Scandinavica

Volumn 63, Issue 3, 1981, Pages 262-271

  Vaisanen K ^a   Viukari, M ^a   Rimon R ^a   Raisanen P ^a  

^a The Central Institute of Vaalijala for the Mentally Retarded ^*  (Finland)

Author keywords

drug holidays; haloperidol; Oligophrenia; placebo; restlessness; serum levels; thioridazine

Indexed keywords

HALOPERIDOL; THIORIDAZINE;

CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMPARISON; DRUG RESPONSE; HUMAN; MAJOR CLINICAL STUDY; MENTAL DEFICIENCY; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; THERAPY;

ADOLESCENT; ADULT; CLINICAL TRIALS; FEMALE; HALOPERIDOL; HUMAN; MALE; MENTAL RETARDATION; MESORIDAZINE; MIDDLE AGE; PLACEBOS; PSYCHOMOTOR AGITATION; RANDOM ALLOCATION; THIORIDAZINE;

EID: 0019455862     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1981.tb00673.x     Document Type: Article

References (12)

1. Medication antiparkin‐sonienne et bilan extra‐pyramidal: étude du trihexyphenidyl
2. The effect of chlorpromazine on serum cholesterol in chronic schizophrenic patients
3. Comparative doses and costs of antipsychotic medication
4. A gas chromatographic method for determining haloperidol
5. Individual variability in response to haloperidol
6. Effect of anticonvulsants on plasma haloperidol and thioridazine levels
7. Plasma thioridazine and therapeutic response in schizophrenia
8. A method for the fluorimetric determination of thioridazine (Melleril®) or Mesoridazine (Lidanil®) in plasma
9. Intermittent pharmacotherapy in chronic schizophrenia
10. Further studies on the effect of butyrophenones on cholesterol synthesis in humans
11. Blood levels of neuroleptic drugs in non‐responding chronic schizophrenic patients
12. Assay procedures for thioridazine, trifluoperazine, and their sulfoxides and determination of urinary excretion of these compounds in mental patients